This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Mar 20;123(12):1776-7.

doi: 10.1182/blood-2014-01-551267.

Changing myelofibrosis's natural course at last

Srdan Verstovsek¹

Affiliations

PMID: 24652960
DOI: 10.1182/blood-2014-01-551267

Free article

Comment

Changing myelofibrosis's natural course at last

Srdan Verstovsek. Blood. 2014.

Free article

. 2014 Mar 20;123(12):1776-7.

doi: 10.1182/blood-2014-01-551267.

Author

Srdan Verstovsek¹

Affiliation

¹ THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER.

PMID: 24652960
DOI: 10.1182/blood-2014-01-551267

No abstract available

PubMed Disclaimer

Comment on

Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts.
Passamonti F, Maffioli M, Cervantes F, Vannucchi AM, Morra E, Barbui T, Caramazza D, Pieri L, Rumi E, Gisslinger H, Knoops L, Kiladjian JJ, Mora B, Hollaender N, Pascutto C, Harrison C, Cazzola M. Passamonti F, et al. Blood. 2014 Mar 20;123(12):1833-5. doi: 10.1182/blood-2013-12-544411. Epub 2014 Jan 17. Blood. 2014. PMID: 24443442 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations